Aequo's attorneys have successfully defended the intellectual property rights of the Ukrainian pharmaceutical company “Darnitsa” to “Citramon” trademark.

On December 2, 2020, the Commercial Court of the City of Kyiv rendered its judgement, by which cancelled the trademark certificate No. 225918 for "Citramon-Health", owned by Zdorovye Pharmaceutical Group, on the basis of its confusing similarity to Darnitsa trademark.

Darnitsa has a longstanding history of defending its rights to “Citramon”. Earlier, the court cancelled the state registration for the pharmaceutical product "Citramon-Health", manufactured by Zdorovye Pharmaceutical Company, due to the infringement of Darnitsa intellectual property rights.

Tetiana Kudrytska, counsel at Aequo, comments: "The judgement in this case brings clarity to the longstanding dispute over the rights to Citramon trademark. We are pleased to have the opportunity to work on this project andare confident that this Darnitsa’s victory will help to achieve client's strategic goals for establishing an international pharmaceutical brand”.

The project was led by Tetiana Kudrytska, counsel, and Alina Podolyak, senior associate, Aequo’s intellectual property practice.